NM_139058.3:c.333_335delGGC

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP3BP6_Very_StrongBS1BS2

The NM_139058.3(ARX):​c.333_335delGGC​(p.Ala112del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000915 in 760,402 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 62 hemizygotes in GnomAD. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A111A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., 6 hem., cov: 22)
Exomes 𝑓: 0.0010 ( 0 hom. 56 hem. )

Consequence

ARX
NM_139058.3 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.33

Publications

0 publications found
Variant links:
Genes affected
ARX (HGNC:18060): (aristaless related homeobox) This gene is a homeobox-containing gene expressed during development. The expressed protein contains two conserved domains, a C-peptide (or aristaless domain) and the prd-like class homeobox domain. It is a member of the group-II aristaless-related protein family whose members are expressed primarily in the central and/or peripheral nervous system. This gene is thought to be involved in CNS development. Expansion of a polyalanine tract and other mutations in this gene cause X-linked cognitive disability and epilepsy. [provided by RefSeq, Jul 2016]
ARX Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD, XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • intellectual disability, X-linked, with or without seizures, ARX-related
    Inheritance: XL Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, G2P
  • Partington syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked lissencephaly with abnormal genitalia
    Inheritance: XL Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • corpus callosum agenesis-abnormal genitalia syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile epileptic-dyskinetic encephalopathy
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked spasticity-intellectual disability-epilepsy syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_139058.3
BP6
Variant X-25013659-TGCC-T is Benign according to our data. Variant chrX-25013659-TGCC-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 416368.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000247 (26/105432) while in subpopulation EAS AF = 0.00124 (4/3218). AF 95% confidence interval is 0.000424. There are 0 homozygotes in GnomAd4. There are 6 alleles in the male GnomAd4 subpopulation. Median coverage is 22. This position passed quality control check.
BS2
High AC in GnomAd4 at 26 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_139058.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARX
NM_139058.3
MANE Select
c.333_335delGGCp.Ala112del
disruptive_inframe_deletion
Exon 2 of 5NP_620689.1Q96QS3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARX
ENST00000379044.5
TSL:1 MANE Select
c.333_335delGGCp.Ala112del
disruptive_inframe_deletion
Exon 2 of 5ENSP00000368332.4Q96QS3

Frequencies

GnomAD3 genomes
AF:
0.000247
AC:
26
AN:
105426
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.000471
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000970
Gnomad ASJ
AF:
0.000392
Gnomad EAS
AF:
0.00124
Gnomad SAS
AF:
0.000394
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000989
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
6
Gnomad NFE exome
AF:
0.00
GnomAD4 exome
AF:
0.00102
AC:
670
AN:
654970
Hom.:
0
AF XY:
0.000285
AC XY:
56
AN XY:
196330
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00142
AC:
18
AN:
12714
American (AMR)
AF:
0.00800
AC:
11
AN:
1375
Ashkenazi Jewish (ASJ)
AF:
0.00252
AC:
11
AN:
4368
East Asian (EAS)
AF:
0.00419
AC:
17
AN:
4053
South Asian (SAS)
AF:
0.000633
AC:
8
AN:
12636
European-Finnish (FIN)
AF:
0.0105
AC:
23
AN:
2194
Middle Eastern (MID)
AF:
0.00341
AC:
4
AN:
1172
European-Non Finnish (NFE)
AF:
0.000909
AC:
540
AN:
594345
Other (OTH)
AF:
0.00172
AC:
38
AN:
22113
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.327
Heterozygous variant carriers
0
67
133
200
266
333
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000247
AC:
26
AN:
105432
Hom.:
0
Cov.:
22
AF XY:
0.000194
AC XY:
6
AN XY:
30934
show subpopulations
African (AFR)
AF:
0.000470
AC:
14
AN:
29785
American (AMR)
AF:
0.0000969
AC:
1
AN:
10315
Ashkenazi Jewish (ASJ)
AF:
0.000392
AC:
1
AN:
2550
East Asian (EAS)
AF:
0.00124
AC:
4
AN:
3218
South Asian (SAS)
AF:
0.000396
AC:
1
AN:
2524
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4214
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
187
European-Non Finnish (NFE)
AF:
0.0000989
AC:
5
AN:
50535
Other (OTH)
AF:
0.00
AC:
0
AN:
1464
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000266
Hom.:
2

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
ARX-related disorder (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Intellectual disability, X-linked, with or without seizures, ARX-related;C3463992:Developmental and epileptic encephalopathy, 1 (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.3
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs387906492; hg19: chrX-25031776; COSMIC: COSV109439288; COSMIC: COSV109439288; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.